Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression

Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression

OBJECTIVE: To evaluate long-term safety and efficacy of esketamine nasal spray plus a new oral antidepressant (OAD) in patients with treatment-resistant depression (TRD). METHODS: This phase 3, open-label, multicenter, long-term (up to 1 year) study was conducted between October 2015 and October 201...

Full description

Bibliographic Details
Main Authors: Wajs, Ewa, Aluisio, Leah, Holder, Richard, Daly, Ella J., Lane, Rosanne, Lim, Pilar, George, Joyce E., Morrison, Randall L., Sanacora, Gerard, Young, Allan H., Kasper, Siegfried, Sulaiman, Ahmad Hatim, Li, Cheng Ta, Paik, Jong Woo, Manji, Husseini, Hough, David, Grunfeld, Jennifer, Jeon, Hong Jin, Wilkinson, Samuel T., Drevets, Wayne C., Singh, Jaskaran B.
Format: Article
Published: Physicians Postgraduate Press 2020
Subjects:
R Medicine

Similar Items